How Can Dendritic Cell Vaccines Help Patients With Cancer?
A Turning Point for Cancer Vaccines
Dendritic cell vaccine for MM: Trial updates with maintenance & checkpoint inhibitor pidilizumab
Cancer Vaccines: Jump Starting an Immune Response to Cancer
Dendritic cells (DCs) are powerful antigen presenting cells for the induction of antigen specific T cell response. DC vaccine has been introduced as a new therapeutic strategy in cancer patients. DC-based immunotherapy is safe and can promote antitumor immune responses and prolonged survival of cancer patients.
Explore contextually related video stories in a new eye-catching way. Try Combster now!